American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease
Abstract: Background: Prevention and management of end-organ disease represent major challenges facing providers of children and adults with sickle cell disease (SCD).Uncertainty and variability in the screening, diagnosis, and management of cardiopulmonary and renal complications in SCD lead to varying outcomes for affected individuals.Objective: